Expression from the murine p53 promoter is mediated by factor binding to a downstream helix-loop-helix recognition motif.
- 15 May 1991
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 88 (10) , 4128-4132
- https://doi.org/10.1073/pnas.88.10.4128
Abstract
Expression of the p53 gene plays an important role in the regulation of cellular proliferation and malignant transformation. Overexpression of mutant forms of p53 is in fact a common feature of many transformed cells. Studies dealing with the transcriptional regulatory regions of the p53 gene indicate that, unlike most promoters transcribed by RNA polymerase II, the p53 promoter contains no TATA-like sequence upstream of the transcription start site. Here we demonstrate that the murine p53 promoter contains a cis-acting element that maps downstream to the transcription initiation site. The integrity of this element is required for high-level expression from the promoter in transformed cells. By DNase I protection and mobility-shift analysis, we show that a nuclear factor binds to this downstream element through the consensus recognition sequence for the helix-loop-helix (HLH)-containing proteins of the myc/MyoD family of transcriptional regulators. We propose that the activity of one or more members of this family of transcription factors is an important determinant in the expression of p53 and that at least one level of p53 overexpression in transformed cells may thus be due to aberrant expression of the relevant factor(s). Furthermore, the possibility that the regulation of expression of p53 occurs, in part, by means of a potential HLH-containing factor provides a possible mechanism for the suppression of proliferation by the MyoD family of transcriptional regulators.Keywords
This publication has 53 references indexed in Scilit:
- Nuclear factor-1 (NF-1) binds to multiple sites within the transcriptional enhancer of Moloney Murine Leukemia virusFEBS Letters, 1990
- MyoD family: a paradigm for development?Genes & Development, 1990
- Mutations in the p53 gene occur in diverse human tumour typesNature, 1989
- MyoD is a sequence-specific DNA binding protein requiring a region of myc homology to bind to the muscle creatine kinase enhancerCell, 1989
- lyl-1, a novel gene altered by chromosomal translocation in T cell leukemia, codes for a protein with a helix-loop-helix DNA binding motifCell, 1989
- The murine p53 protein blocks replication of SV40 DNA in vitro by inhibiting the initiation functions of SV40 large T antigenCell, 1989
- The “initiator” as a transcription control elementCell, 1989
- p53 and DNA polymerase α compete for binding to SV40 T antigenNature, 1987
- Participation of p53 cellular tumour antigen in transformation of normal embryonic cellsNature, 1984
- Isolation of biologically active ribonucleic acid from sources enriched in ribonucleaseBiochemistry, 1979